EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Specific IgE and Basophil Activation Test by Microarray: A Promising Tool for Diagnosis of Platinum Compound Hypersensitivity Reactions

Carlos Fernández-Lozano, Claudia Geraldine Rita iD, Alicia Barra-Castro iD, Belén de la Hoz Caballer, Ernesto Roldán, Cristina Pueyo López iD, Javier Martinez-Botas iD, María Pilar Berges-Gimeno

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25073890 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Carlos Fernández-Lozano und 7 weiteren Autor:innen. Beteiligte Einrichtung: Biochemistry-Research Department, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria, Carretera de Colmenar Km …. Hauptthemen laut MEDLINE: Drug Hypersensitivity, Polychaeta, Radiation-Sensitizing Agents, Hypersensitivity, Immediate. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, Fundación Merck Salud, European Regional Development Fund (ERDF).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Drug hypersensitivity reactions (DHRs) to platinum-based compounds (PCs) are on the rise, and their personalized and safe management is essential to enable first-line treatment for these cancer patients. This study aimed to evaluate the usefulness of the basophil activation test by flow cytometry (BAT-FC) and the newly developed sIgE-microarray and BAT-microarray in diagnosing IgE-mediated hypersensitivity reactions to PCs. A total of 24 patients with DHRs to PCs (20 oxaliplatin and four carboplatin) were evaluated: thirteen patients were diagnosed as allergic with positive skin tests (STs) or drug provocation tests (DPTs), six patients were diagnosed as non-allergic with negative STs and DPTs, and five patients were classified as suspected allergic because DPTs could not be performed. In addition, four carboplatin-tolerant patients were included as controls. The BAT-FC was positive in 2 of 13 allergic patients, with a sensitivity of 15.4% and specificity of 100%. However, the sIgE- and BAT-microarray were positive in 11 of 13 DHR patients, giving a sensitivity of over 84.6% and a specificity of 90%. Except for one patient, all samples from the non-allergic and control groups were negative for sIgE- and BAT-microarray. Our experience indicated that the sIgE- and BAT-microarray could be helpful in the endophenotyping of IgE-mediated hypersensitivity reactions to PCs and may provide an advance in decision making for drug provocation testing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug HypersensitivityPolychaetaRadiation-Sensitizing AgentsHypersensitivity, ImmediateThionesHumansAnimalsBasophil Degranulation TestPlatinum CompoundsCarboplatinAntineoplastic Agents, AlkylatingImmunoglobulin E

Stichwörter der Autor:innen

basophil activation testdrug allergieshypersensitivity reactionmicroarrayplatinum compounds

Substanzen

Platinum CompoundsdiphenylthiosulfinateCarboplatinAntineoplastic Agents, AlkylatingRadiation-Sensitizing AgentsImmunoglobulin EThiones

Autor:innen und Institutionen

  • Biochemistry-Research Department, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria, Carretera de Colmenar Km 9, 28034 Madrid, Spain.
  • Allergology Department, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria, Carretera de Colmenar Km 9, 28034 Madrid, Spain.
  • Immunology Service, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria, Carretera de Colmenar Km 9, 28034 Madrid, Spain.
  • Department of Medicine and Health Sciences, Alcalá University, 28801 Madrid, Spain.
  • Pharmacy Department, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria, Carretera de Colmenar Km 9, 28034 Madrid, Spain.

ORCID-Profile: Claudia Geraldine Rita, Alicia Barra-Castro, Cristina Pueyo López, Javier Martinez-Botas

Förderung

  • Instituto de Salud Carlos III
  • Fundación Merck Salud
  • European Regional Development Fund (ERDF)
  • Fundación Merck Salud, Spain [Ayudas Merck de investigación, 2019]

Zitieren

APA

Fernández-Lozano, C., Rita, C. G., Barra-Castro, A., de la Hoz Caballer, B., Roldán, E., Pueyo López, C., Martinez-Botas, J., & Berges-Gimeno, M. P. (2024). Specific IgE and Basophil Activation Test by Microarray: A Promising Tool for Diagnosis of Platinum Compound Hypersensitivity Reactions. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25073890

Vancouver

Fernández-Lozano C, Rita CG, Barra-Castro A, de la Hoz Caballer B, Roldán E, Pueyo López C, et al. Specific IgE and Basophil Activation Test by Microarray: A Promising Tool for Diagnosis of Platinum Compound Hypersensitivity Reactions. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25073890

BibTeX
@article{FernndezLozano2024,
  author = {Fernández-Lozano, Carlos and Rita, Claudia Geraldine and Barra-Castro, Alicia and de la Hoz Caballer, Belén and Roldán, Ernesto and Pueyo López, Cristina and Martinez-Botas, Javier and Berges-Gimeno, María Pilar},
  title = {Specific IgE and Basophil Activation Test by Microarray: A Promising Tool for Diagnosis of Platinum Compound Hypersensitivity Reactions},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25073890}
}
Kostenlos starten →